SlideShare a Scribd company logo
CARCINOMA ORAL CAVITY PART
1
PRESENTER- Dr. ABHISHEK MEWARA
MODERATOR- Dr. UPEN K MATHUR
DATE- 16.05.2024
1
OVERVIEW-
1. INTRODUCTION
2. INCIDENCE, EPIDEMIOLOGY AND ETIOLOGY
3. ANATOMY
4. MOLECULAR BIOLOGY
5. NATURAL HISTORY- THE PREMALIGNANT LESIONS
6. PATTERN OF SPREAD
7. PATHOLOGICAL CLASSIFICATION
8. STAGING
2
1. INTRODUCTION
3
 SCC of the lip and oral cavity is primarily a surgical disease.
 Two clinical pathways for the subsequent management:
1. For early stage disease.
2. For locally advanced disease.
 Surgery is the preferred treatment approach for early stage T1 or T2N0 lesions of the oral
cavity or lip.
 For more advanced disease (T3/T4a, N0 or T1-T4a, N1-N3), a combined modality
approach is adopted involving surgery followed by adjuvant RT or CTRT.
4
5
CA LIP
6
7
CA TONGUE, FLOOR OF MOUTH, BUCCAL MUCOSA, HARD PALATE,
ALVEOLAR RIDGE, AND RETROMOLAR TRIGONE
8
2. INCIDENCE,
EPIDEMIOLOGY AND
ETIOLOGY
9
10
11
RISK FACTORS-
1. TOBACCO- 5 to 25 times increased risk.
2. ALCOHOL
3. SMOKING
4. BETEL NUT
5. UV RADIATION- Particularly Ca lip.
6. HPV- M/C HPV 16
7. SYNDROMES- Xeroderma pigmentosum, Li-Fraumeni, Ataxia telangiectasia, Bloom
syndrome, and Fanconi anemia.
12
3. ANATOMY
13
 The oral cavity consists of the lips, oral tongue, floor of the mouth,
retromolar trigone, alveolar ridge, buccal mucosa, and hard palate.
 The anterior boundary is the skin–vermilion junction.
 The superior portion extends posteriorly to the junction between the
hard and soft palate, whereas the inferior portion extends to the
circumvallate papillae.
14
15
A. LIP-
 Begins at the junction of the vermilion border with the skin and form the
anterior aspect of the oral vestibule.
 Vermilion surface is the portion of the lip that comes in contact with the
opposing lip.
 The primary motor control is by the buccal and mandibular branches of the
facial nerve.
16
B. ORAL TONGUE-
 The anterior two-third is mobile and is part of the oral cavity.
 Extends anteriorly from the circumvallate papillae to the undersurface of the tongue at the
junction of the floor of the mouth.
 Demarcated into 4 areas: the tip, lateral borders, dorsal surface, and undersurface (ventral
surface).
 6 pair of muscles form the oral tongue. 3 are extrinsic, 3 are intrinsic.
 Extrinsic muscles include the genioglossus, hyoglossus, and styloglossus.
 Intrinsic muscles include the lingual, vertical, and transverse muscles.
 The former primarily move the body of the tongue, whereas the latter alter the shape and
conformation of the tongue during speech and swallowing.
17
 Arterial supply: Lingual artery, tonsillar branch of the facial artery, and the ascending
pharyngeal artery.
 Venous drainage: Internal jugular vein.
 General sensation of the anterior two-thirds of the tongue: Lingual nerve.
 Excluding the circumvallate papillae, taste fibers from the anterior two-thirds of the tongue
run in the Chorda tympani branch of the facial nerve; and the glossopharyngeal nerve
provides sensation and taste to the posterior third of the tongue and circumvallate papillae.
18
3. FLOOR OF THE MOUTH-
 Semilunar space extending from the lower alveolar ridge to the undersurface of
the tongue.
 Overlies the mylohyoid and hyoglossus muscles.
 The posterior boundary is the base of the anterior tonsillar pillar.
 Innervation of the floor of the mouth is provided by the lingual nerve.
19
4. HARD PALATE- Extends from the inner surface of the superior alveolar ridge to the posterior edge
of the palatine bone.
5. ALVEOLAR RIDGE- Includes the alveolar processes of the maxilla and mandible and the overlying
mucosa.
6. RETROMOLAR TRIGONE- A triangular area overlying the ascending ramus of the mandible. The
base of the triangle is formed by the posterior most molar, and the apex lies at the maxillary
tuberosity.
7. BUCCAL MUCOSA- Includes the mucosal surfaces of the cheek and lips from the line of contact of
the opposing lips to the pterygomandibular raphe posteriorly. Innervation is by the buccal nerve, a
branch of the mandibular nerve.
20
21
8. NODAL LEVELS- There are 5 primary nodal levels, plus the retropharyngeal
nodes, that are relevant to the staging and management of oral cavity carcinoma.
a) LEVEL I - submental (Ia) and submandibular (Ib) nodes.
b) LEVEL II - upper jugular chain lymph nodes. The level II nodal region is further
subdivided into IIa and IIb (anterior and posterior respectively).
c) LEVEL III - caudal extension of level II. Includes the mid-jugular nodes.
d) LEVEL IV - inferior jugular nodes.
e) LEVEL V - nodes in the posterior triangle, which are located posterior to the
sternocleidomastoid muscle.
f) Retropharyngeal nodes.
22
23
4. MOLECULAR BIOLOGY
24
 Several steps occur during tumor development, viz oncogenes become activated, and
tumor suppressor genes become deactivated.
 In the oral mucosa, this genetic progression is reflected histologically by the
transformation from normal mucosa to dysplastic epithelium, and ultimately to frankly
invasive squamous cell carcinoma.
 Loss of heterozygosity at chromosomes 3p14 and 9p21 is documented as being involved
in tumor development.
 Mutations in the region of chromosome 17p13, which encompasses the tumor suppressor
gene TP53, are among early events that contribute to malignant transformation.
25
 Known tumor suppressor genes and oncogenes were found to be mutated,
including TP53, PIK3CA, PTEN, HRAS, and CDKN2A.
 Loss-of-function mutations in NOTCH1 can cause tumor development.
 Activating mutations in HRAS or PIK3CA are associated with improved clinical
outcomes.
 Other clinically important IHC markers are p16, p40, p53 etc.
 Smoking was seen to have a minimal effect on genomic changes.
26
5. NATURAL HISTORY- THE
PREMALIGNANT LESIONS
27
A. LEUKOPLAKIA-
 A white patch or plaque that cannot be rubbed off, and cannot be
characterized clinically or pathologically as any other disease.
 Most common precursor of cancer of the oral cavity.
 Hyperkeratosis and acanthosis- morphological hallmark.
 Begin as a thin gray or gray/ white plaque that may appear translucent, is
sometimes fissured or wrinkled, and typically soft and flat.
 Frequently have sharply demarcated borders.
28
 Pathology: High-risk oral leukoplakia shows abnormal orientation of cells,
nuclear hyperchromatism, increased mitosis and nuclear cytoplasmic ratio.
 1% to 18% of oral leukoplakia develops into oral cancer.
 May regress spontaneously without therapy.
 A baseline biopsy may be performed to establish diagnosis and rule out
malignant transformation.
 Leukoplakia with clinically or histologically aggressive features,
demonstrating dysplasia, should be excised.
29
30
B. ERYTHROPLAKIA-
 A chronic, red, generally asymptomatic lesion or patch on the mucosal surface that cannot
be attributed to a traumatic, vascular, or inflammatory cause.
 Erythroplakia, like leukoplakia, is a clinical diagnosis of exclusion that requires the
clinician to rule out all other erythematous oral lesions.
 Associated with a higher risk of malignant transformation than leukoplakia.
 The treatment of choice is surgical excision.
31
32
C. ORAL SUBMUCOUS FIBROSIS-
 A generalized fibrosis of the oral cavity tissues resulting in marked rigidity and trismus.
 At early stages, it is characterized by blanching of the mucosa with a marble-like
appearance.
 At more advanced stages, palpable fibrous bands become evident around the buccal
mucosa and the mouth opening is compromised.
 In India, it is estimated that nearly 5 million individuals are affected with oral submucous
fibrosis, due to the abuse of betel nut and pan masala.
33
34
D. ORAL CAVITY CANCER-
 Carcinoma of buccal mucosa is the most common carcinoma of the oral
cavity in Southeast Asia because of the widespread abuse of betel nut and
pan masala.
 The second most common site is tongue.
 The third most common site is the floor of the mouth.
 Carcinoma of the alveolar ridge, retromolar trigone and hard palate are other
rare types.
35
6. PATTERN OF SPREAD
36
A. LOCAL SPREAD-
 Majority of lip cancers are local growths that do not invade deeply into the
tissues of the oral cavity or mandible.
 Floor of the mouth cancers can secondarily involve the ventral tongue, extend
along the lingual nerve and submandibular duct, or invade the cortex of the
mandible. Tumors in this location can invade deeply, involving the muscles of
the floor of the mouth. Also, there is an anatomical gap between the
mylohyoid and hyoglossus muscles through which a carcinoma can gain
access to submandibular and sublingual areas.
37
 Alveolar ridge and retromolar trigone cancers tend to invade bone early.
Tumors of the inferior alveolar ridge may access the mandibular canal and
the inferior alveolar nerve, whereas tumors of the superior alveolar ridge
may pass into the maxillary antrum or floor of the nose.
 Buccal mucosa cancer can invade the buccinator muscle, extend to the
buccal fat pad, and invade the subcutaneous tissue.
38
B. LYMPHATIC SPREAD-
 The retro-styloid space is potentially at risk for involvement by metastatic disease when
upper level II nodes are involved.
 The principal lymphatic drainage of the upper lip is to preauricular, peri-parotid,
submental, and submandibular lymph nodes.
 The medial portion of the lower lip drains primarily to the submental lymph nodes,
whereas the lateral portion drains to the submandibular triangle.
 The anterior portion of the tongue drains to the submental nodes, and the lateral
portion drains to the submandibular and deep jugular nodes. The posterior oral tongue
drains into the upper jugulodigastric group of lymph nodes.
39
 The lymphatics of the oral tongue have extensive communication across the midline,
thus carcinomas of the oral tongue can metastasize bilaterally.
 Some carcinomas of the lateral oral tongue may metastasize to level IV lymph nodes
without involving levels I, II, or III. This implies that there may be separate lymphatic
channels draining from the oral tongue directly to level IV nodes, allowing for apparent
“skip metastases.”
 The floor of the mouth has superficial and deep lymphatic drainage systems. The
superficial system crosses randomly in the midline and drains into both the ipsilateral
and contralateral submandibular lymph nodes.
40
C. DISTANT METASTASIS-
 The risk of distant metastases increases with the degree of
lymph node involvement.
 Patients with recurrent disease are also at higher risk for distant
metastases.
 In general terms, 66% of distant metastases are to the lungs,
22% to the bones, and 9.5% to the liver.
41
7. PATHOLOGICAL CLASSIFICATION
42
 The predominant histopathologic type of cancer in the oral cavity is squamous cell carcinoma.
 2 main variants of squamous cell carcinoma, including basaloid and verrucous carcinoma, and
other variant being sarcomatoid carcinoma.
 Basaloid squamous cell carcinoma has a worse prognosis due to higher incidence of
advanced disease at presentation, distant metastases, and poorer overall survival rate.
 Verrucous carcinoma is a less common variant of squamous cell carcinoma. It is generally
considered a low-grade malignancy with low metastatic potential and good overall prognosis
 Sarcomatoid carcinomas carry a poor prognosis, with a mean survival of approximately 2
years.
43
 < 10% of neoplasms of the oral cavity have non-squamous histology.
 Most of these are minor salivary gland tumors, which tend to arise in the hard palate.
 Adenoid cystic carcinoma accounts for approximately 30% to 40% of minor salivary
gland cancers of the oral cavity.
 Other types includes adenocarcinomas, melanoma, ameloblastoma, lymphoma, and
Kaposi sarcoma.
 Most lymphomas in the head and neck arise in Waldeyer ring (tonsil, base of the tongue,
and nasopharynx).
 Melanomas are also present, with mucosal melanomas generally having a worse
prognosis than cutaneous melanomas.
44
8. STAGING
(AJCC 8th Ed.)
45
 There are several pertinent changes from prior editions of the AJCC Staging
Manual:
(a) Clinical and pathologic depth of invasion are now used in indicating the T
category.
(b) Extrinsic tongue muscle involvement is no longer denoted as T4.
(c) Separate N staging categories are now present for patients treated with and
without neck dissection.
(d) The presence of extra-nodal extension (ENE) is introduced as a descriptor of
HPV negative squamous cell carcinoma.
46
47
48
49
50
REFERENCES-
1. PEREZ & BRADY’S
2. DHINGRA’S ENT
3. ROBBINS PATHOLOGY
4. NCCN v.2018
5. GLOBOCAN 2022
6. AJCC 8TH Edition
51
CA ORAL CAVITY PART 2
1. CLINICAL PRESENTATION
2. DIAGNOSTIC EVALUATION
3. MANAGEMENT-
a) GENERAL OVERVIEW
b) SURGERY
c) RADIATION THERAPY
d) CHEMOTHERAPY
52
THANK YOU, AND
HAVE A NICE DAY!
53

More Related Content

Similar to 9. Oral cavity cancer presentation Part 1.pptx

Tongue cancer
Tongue cancerTongue cancer
Tongue cancer
Dr.Bashab Roy
 
Pre-management in Head and Neck Cancers.pptx
Pre-management in Head and Neck Cancers.pptxPre-management in Head and Neck Cancers.pptx
Pre-management in Head and Neck Cancers.pptx
BonnieRKSingh1
 
Pre management in Head and Neck Cancers.pptx
Pre management in Head and Neck Cancers.pptxPre management in Head and Neck Cancers.pptx
Pre management in Head and Neck Cancers.pptx
bONNIErk
 
Oral cavity & neck
Oral cavity & neckOral cavity & neck
Oral cavity & neck
Ankita Singh
 
Tongue Anatomy & Carinoma
Tongue Anatomy & CarinomaTongue Anatomy & Carinoma
Tongue Anatomy & Carinoma
Mahmoud Mo'ness
 
ORAL CAVITY.pptx
ORAL CAVITY.pptxORAL CAVITY.pptx
ORAL CAVITY.pptx
Kiran Ramakrishna
 
ORAL MALIGNANCIES M.pptx
ORAL MALIGNANCIES M.pptxORAL MALIGNANCIES M.pptx
ORAL MALIGNANCIES M.pptx
MohammedMujtaba38
 
Maxillary Sinus
Maxillary SinusMaxillary Sinus
Maxillary Sinus
Ahmed Adawy
 
Oral cavity malignancy.pptx
Oral cavity malignancy.pptxOral cavity malignancy.pptx
Oral cavity malignancy.pptx
Deepakkumar478017
 
Carcinoma buccal mucosa
Carcinoma buccal mucosaCarcinoma buccal mucosa
Carcinoma buccal mucosa
Abhilash Gavarraju
 
Ca tongue.pptx
Ca tongue.pptxCa tongue.pptx
Ca tongue.pptx
SHAKIBUL ALAM
 
Oral Cancer
Oral CancerOral Cancer
Oral Cancer
Dr. Valluri Mukesh
 
73rd publication iosr jdms - 7th name
73rd publication  iosr jdms - 7th name73rd publication  iosr jdms - 7th name
73rd publication iosr jdms - 7th name
CLOVE Dental OMNI Hospitals Andhra Hospital
 
Diseases of oral cav, nasoph and oroph
Diseases of oral cav, nasoph and orophDiseases of oral cav, nasoph and oroph
Diseases of oral cav, nasoph and orophspecialclass
 
Inverted papilloma
Inverted papillomaInverted papilloma
Inverted papilloma
Mohammed Nishad N
 
invertedpapilloma-200629130120.pdf
invertedpapilloma-200629130120.pdfinvertedpapilloma-200629130120.pdf
invertedpapilloma-200629130120.pdf
saitsulimani
 
Oral caner
Oral canerOral caner
Pharynx Lecture_3.doc
Pharynx Lecture_3.docPharynx Lecture_3.doc
Pharynx Lecture_3.doc
SumitKumar2316
 
Cleft lip and palate.pptx
Cleft lip and palate.pptxCleft lip and palate.pptx
Cleft lip and palate.pptx
03KomeshAniketCheekh
 

Similar to 9. Oral cavity cancer presentation Part 1.pptx (20)

Tongue cancer
Tongue cancerTongue cancer
Tongue cancer
 
Pre-management in Head and Neck Cancers.pptx
Pre-management in Head and Neck Cancers.pptxPre-management in Head and Neck Cancers.pptx
Pre-management in Head and Neck Cancers.pptx
 
Pre management in Head and Neck Cancers.pptx
Pre management in Head and Neck Cancers.pptxPre management in Head and Neck Cancers.pptx
Pre management in Head and Neck Cancers.pptx
 
Oral cavity & neck
Oral cavity & neckOral cavity & neck
Oral cavity & neck
 
Tongue Anatomy & Carinoma
Tongue Anatomy & CarinomaTongue Anatomy & Carinoma
Tongue Anatomy & Carinoma
 
ORAL CAVITY.pptx
ORAL CAVITY.pptxORAL CAVITY.pptx
ORAL CAVITY.pptx
 
ORAL MALIGNANCIES M.pptx
ORAL MALIGNANCIES M.pptxORAL MALIGNANCIES M.pptx
ORAL MALIGNANCIES M.pptx
 
Maxillary Sinus
Maxillary SinusMaxillary Sinus
Maxillary Sinus
 
Oral cavity malignancy.pptx
Oral cavity malignancy.pptxOral cavity malignancy.pptx
Oral cavity malignancy.pptx
 
Carcinoma buccal mucosa
Carcinoma buccal mucosaCarcinoma buccal mucosa
Carcinoma buccal mucosa
 
Ca tongue.pptx
Ca tongue.pptxCa tongue.pptx
Ca tongue.pptx
 
Oral Cancer
Oral CancerOral Cancer
Oral Cancer
 
73rd publication iosr jdms - 7th name
73rd publication  iosr jdms - 7th name73rd publication  iosr jdms - 7th name
73rd publication iosr jdms - 7th name
 
Diseases of oral cav, nasoph and oroph
Diseases of oral cav, nasoph and orophDiseases of oral cav, nasoph and oroph
Diseases of oral cav, nasoph and oroph
 
Inverted papilloma
Inverted papillomaInverted papilloma
Inverted papilloma
 
invertedpapilloma-200629130120.pdf
invertedpapilloma-200629130120.pdfinvertedpapilloma-200629130120.pdf
invertedpapilloma-200629130120.pdf
 
Oral caner
Oral canerOral caner
Oral caner
 
Pharynx Lecture_3.doc
Pharynx Lecture_3.docPharynx Lecture_3.doc
Pharynx Lecture_3.doc
 
Cleft lip and palate.pptx
Cleft lip and palate.pptxCleft lip and palate.pptx
Cleft lip and palate.pptx
 
1)metastatic neck disease
1)metastatic neck disease1)metastatic neck disease
1)metastatic neck disease
 

More from AbhishekMewara2

10. Oral cavity cancer presentation Part 2.pptx
10. Oral cavity cancer presentation Part 2.pptx10. Oral cavity cancer presentation Part 2.pptx
10. Oral cavity cancer presentation Part 2.pptx
AbhishekMewara2
 
8. Breast Cancer Diagnostic Workup .pptx
8. Breast Cancer Diagnostic Workup .pptx8. Breast Cancer Diagnostic Workup .pptx
8. Breast Cancer Diagnostic Workup .pptx
AbhishekMewara2
 
7. Principles of Brachytherapy Part 2.pptx
7. Principles of Brachytherapy Part 2.pptx7. Principles of Brachytherapy Part 2.pptx
7. Principles of Brachytherapy Part 2.pptx
AbhishekMewara2
 
6. Principles of Brachytherapy Part 1.pptx
6. Principles of Brachytherapy Part 1.pptx6. Principles of Brachytherapy Part 1.pptx
6. Principles of Brachytherapy Part 1.pptx
AbhishekMewara2
 
5. Measurement of Absorbed Dose in Radiation Oncology.pptx
5. Measurement of Absorbed Dose in Radiation Oncology.pptx5. Measurement of Absorbed Dose in Radiation Oncology.pptx
5. Measurement of Absorbed Dose in Radiation Oncology.pptx
AbhishekMewara2
 
4. Isodose Distribution In Radiation Oncology .pptx
4. Isodose Distribution In Radiation Oncology .pptx4. Isodose Distribution In Radiation Oncology .pptx
4. Isodose Distribution In Radiation Oncology .pptx
AbhishekMewara2
 
3. Measurment of Ionizing Radiation.pptx
3. Measurment of Ionizing Radiation.pptx3. Measurment of Ionizing Radiation.pptx
3. Measurment of Ionizing Radiation.pptx
AbhishekMewara2
 
2. Radio sensitivity and cell age in the mitotic cycle.pptx
2. Radio sensitivity and cell age in the mitotic cycle.pptx2. Radio sensitivity and cell age in the mitotic cycle.pptx
2. Radio sensitivity and cell age in the mitotic cycle.pptx
AbhishekMewara2
 
1. History taking in Medical and Radiation Oncology.pptx
1. History taking in Medical and Radiation Oncology.pptx1. History taking in Medical and Radiation Oncology.pptx
1. History taking in Medical and Radiation Oncology.pptx
AbhishekMewara2
 

More from AbhishekMewara2 (9)

10. Oral cavity cancer presentation Part 2.pptx
10. Oral cavity cancer presentation Part 2.pptx10. Oral cavity cancer presentation Part 2.pptx
10. Oral cavity cancer presentation Part 2.pptx
 
8. Breast Cancer Diagnostic Workup .pptx
8. Breast Cancer Diagnostic Workup .pptx8. Breast Cancer Diagnostic Workup .pptx
8. Breast Cancer Diagnostic Workup .pptx
 
7. Principles of Brachytherapy Part 2.pptx
7. Principles of Brachytherapy Part 2.pptx7. Principles of Brachytherapy Part 2.pptx
7. Principles of Brachytherapy Part 2.pptx
 
6. Principles of Brachytherapy Part 1.pptx
6. Principles of Brachytherapy Part 1.pptx6. Principles of Brachytherapy Part 1.pptx
6. Principles of Brachytherapy Part 1.pptx
 
5. Measurement of Absorbed Dose in Radiation Oncology.pptx
5. Measurement of Absorbed Dose in Radiation Oncology.pptx5. Measurement of Absorbed Dose in Radiation Oncology.pptx
5. Measurement of Absorbed Dose in Radiation Oncology.pptx
 
4. Isodose Distribution In Radiation Oncology .pptx
4. Isodose Distribution In Radiation Oncology .pptx4. Isodose Distribution In Radiation Oncology .pptx
4. Isodose Distribution In Radiation Oncology .pptx
 
3. Measurment of Ionizing Radiation.pptx
3. Measurment of Ionizing Radiation.pptx3. Measurment of Ionizing Radiation.pptx
3. Measurment of Ionizing Radiation.pptx
 
2. Radio sensitivity and cell age in the mitotic cycle.pptx
2. Radio sensitivity and cell age in the mitotic cycle.pptx2. Radio sensitivity and cell age in the mitotic cycle.pptx
2. Radio sensitivity and cell age in the mitotic cycle.pptx
 
1. History taking in Medical and Radiation Oncology.pptx
1. History taking in Medical and Radiation Oncology.pptx1. History taking in Medical and Radiation Oncology.pptx
1. History taking in Medical and Radiation Oncology.pptx
 

Recently uploaded

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 

Recently uploaded (20)

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 

9. Oral cavity cancer presentation Part 1.pptx

  • 1. CARCINOMA ORAL CAVITY PART 1 PRESENTER- Dr. ABHISHEK MEWARA MODERATOR- Dr. UPEN K MATHUR DATE- 16.05.2024 1
  • 2. OVERVIEW- 1. INTRODUCTION 2. INCIDENCE, EPIDEMIOLOGY AND ETIOLOGY 3. ANATOMY 4. MOLECULAR BIOLOGY 5. NATURAL HISTORY- THE PREMALIGNANT LESIONS 6. PATTERN OF SPREAD 7. PATHOLOGICAL CLASSIFICATION 8. STAGING 2
  • 4.  SCC of the lip and oral cavity is primarily a surgical disease.  Two clinical pathways for the subsequent management: 1. For early stage disease. 2. For locally advanced disease.  Surgery is the preferred treatment approach for early stage T1 or T2N0 lesions of the oral cavity or lip.  For more advanced disease (T3/T4a, N0 or T1-T4a, N1-N3), a combined modality approach is adopted involving surgery followed by adjuvant RT or CTRT. 4
  • 6. 6
  • 7. 7 CA TONGUE, FLOOR OF MOUTH, BUCCAL MUCOSA, HARD PALATE, ALVEOLAR RIDGE, AND RETROMOLAR TRIGONE
  • 8. 8
  • 10. 10
  • 11. 11
  • 12. RISK FACTORS- 1. TOBACCO- 5 to 25 times increased risk. 2. ALCOHOL 3. SMOKING 4. BETEL NUT 5. UV RADIATION- Particularly Ca lip. 6. HPV- M/C HPV 16 7. SYNDROMES- Xeroderma pigmentosum, Li-Fraumeni, Ataxia telangiectasia, Bloom syndrome, and Fanconi anemia. 12
  • 14.  The oral cavity consists of the lips, oral tongue, floor of the mouth, retromolar trigone, alveolar ridge, buccal mucosa, and hard palate.  The anterior boundary is the skin–vermilion junction.  The superior portion extends posteriorly to the junction between the hard and soft palate, whereas the inferior portion extends to the circumvallate papillae. 14
  • 15. 15
  • 16. A. LIP-  Begins at the junction of the vermilion border with the skin and form the anterior aspect of the oral vestibule.  Vermilion surface is the portion of the lip that comes in contact with the opposing lip.  The primary motor control is by the buccal and mandibular branches of the facial nerve. 16
  • 17. B. ORAL TONGUE-  The anterior two-third is mobile and is part of the oral cavity.  Extends anteriorly from the circumvallate papillae to the undersurface of the tongue at the junction of the floor of the mouth.  Demarcated into 4 areas: the tip, lateral borders, dorsal surface, and undersurface (ventral surface).  6 pair of muscles form the oral tongue. 3 are extrinsic, 3 are intrinsic.  Extrinsic muscles include the genioglossus, hyoglossus, and styloglossus.  Intrinsic muscles include the lingual, vertical, and transverse muscles.  The former primarily move the body of the tongue, whereas the latter alter the shape and conformation of the tongue during speech and swallowing. 17
  • 18.  Arterial supply: Lingual artery, tonsillar branch of the facial artery, and the ascending pharyngeal artery.  Venous drainage: Internal jugular vein.  General sensation of the anterior two-thirds of the tongue: Lingual nerve.  Excluding the circumvallate papillae, taste fibers from the anterior two-thirds of the tongue run in the Chorda tympani branch of the facial nerve; and the glossopharyngeal nerve provides sensation and taste to the posterior third of the tongue and circumvallate papillae. 18
  • 19. 3. FLOOR OF THE MOUTH-  Semilunar space extending from the lower alveolar ridge to the undersurface of the tongue.  Overlies the mylohyoid and hyoglossus muscles.  The posterior boundary is the base of the anterior tonsillar pillar.  Innervation of the floor of the mouth is provided by the lingual nerve. 19
  • 20. 4. HARD PALATE- Extends from the inner surface of the superior alveolar ridge to the posterior edge of the palatine bone. 5. ALVEOLAR RIDGE- Includes the alveolar processes of the maxilla and mandible and the overlying mucosa. 6. RETROMOLAR TRIGONE- A triangular area overlying the ascending ramus of the mandible. The base of the triangle is formed by the posterior most molar, and the apex lies at the maxillary tuberosity. 7. BUCCAL MUCOSA- Includes the mucosal surfaces of the cheek and lips from the line of contact of the opposing lips to the pterygomandibular raphe posteriorly. Innervation is by the buccal nerve, a branch of the mandibular nerve. 20
  • 21. 21
  • 22. 8. NODAL LEVELS- There are 5 primary nodal levels, plus the retropharyngeal nodes, that are relevant to the staging and management of oral cavity carcinoma. a) LEVEL I - submental (Ia) and submandibular (Ib) nodes. b) LEVEL II - upper jugular chain lymph nodes. The level II nodal region is further subdivided into IIa and IIb (anterior and posterior respectively). c) LEVEL III - caudal extension of level II. Includes the mid-jugular nodes. d) LEVEL IV - inferior jugular nodes. e) LEVEL V - nodes in the posterior triangle, which are located posterior to the sternocleidomastoid muscle. f) Retropharyngeal nodes. 22
  • 23. 23
  • 25.  Several steps occur during tumor development, viz oncogenes become activated, and tumor suppressor genes become deactivated.  In the oral mucosa, this genetic progression is reflected histologically by the transformation from normal mucosa to dysplastic epithelium, and ultimately to frankly invasive squamous cell carcinoma.  Loss of heterozygosity at chromosomes 3p14 and 9p21 is documented as being involved in tumor development.  Mutations in the region of chromosome 17p13, which encompasses the tumor suppressor gene TP53, are among early events that contribute to malignant transformation. 25
  • 26.  Known tumor suppressor genes and oncogenes were found to be mutated, including TP53, PIK3CA, PTEN, HRAS, and CDKN2A.  Loss-of-function mutations in NOTCH1 can cause tumor development.  Activating mutations in HRAS or PIK3CA are associated with improved clinical outcomes.  Other clinically important IHC markers are p16, p40, p53 etc.  Smoking was seen to have a minimal effect on genomic changes. 26
  • 27. 5. NATURAL HISTORY- THE PREMALIGNANT LESIONS 27
  • 28. A. LEUKOPLAKIA-  A white patch or plaque that cannot be rubbed off, and cannot be characterized clinically or pathologically as any other disease.  Most common precursor of cancer of the oral cavity.  Hyperkeratosis and acanthosis- morphological hallmark.  Begin as a thin gray or gray/ white plaque that may appear translucent, is sometimes fissured or wrinkled, and typically soft and flat.  Frequently have sharply demarcated borders. 28
  • 29.  Pathology: High-risk oral leukoplakia shows abnormal orientation of cells, nuclear hyperchromatism, increased mitosis and nuclear cytoplasmic ratio.  1% to 18% of oral leukoplakia develops into oral cancer.  May regress spontaneously without therapy.  A baseline biopsy may be performed to establish diagnosis and rule out malignant transformation.  Leukoplakia with clinically or histologically aggressive features, demonstrating dysplasia, should be excised. 29
  • 30. 30
  • 31. B. ERYTHROPLAKIA-  A chronic, red, generally asymptomatic lesion or patch on the mucosal surface that cannot be attributed to a traumatic, vascular, or inflammatory cause.  Erythroplakia, like leukoplakia, is a clinical diagnosis of exclusion that requires the clinician to rule out all other erythematous oral lesions.  Associated with a higher risk of malignant transformation than leukoplakia.  The treatment of choice is surgical excision. 31
  • 32. 32
  • 33. C. ORAL SUBMUCOUS FIBROSIS-  A generalized fibrosis of the oral cavity tissues resulting in marked rigidity and trismus.  At early stages, it is characterized by blanching of the mucosa with a marble-like appearance.  At more advanced stages, palpable fibrous bands become evident around the buccal mucosa and the mouth opening is compromised.  In India, it is estimated that nearly 5 million individuals are affected with oral submucous fibrosis, due to the abuse of betel nut and pan masala. 33
  • 34. 34
  • 35. D. ORAL CAVITY CANCER-  Carcinoma of buccal mucosa is the most common carcinoma of the oral cavity in Southeast Asia because of the widespread abuse of betel nut and pan masala.  The second most common site is tongue.  The third most common site is the floor of the mouth.  Carcinoma of the alveolar ridge, retromolar trigone and hard palate are other rare types. 35
  • 36. 6. PATTERN OF SPREAD 36
  • 37. A. LOCAL SPREAD-  Majority of lip cancers are local growths that do not invade deeply into the tissues of the oral cavity or mandible.  Floor of the mouth cancers can secondarily involve the ventral tongue, extend along the lingual nerve and submandibular duct, or invade the cortex of the mandible. Tumors in this location can invade deeply, involving the muscles of the floor of the mouth. Also, there is an anatomical gap between the mylohyoid and hyoglossus muscles through which a carcinoma can gain access to submandibular and sublingual areas. 37
  • 38.  Alveolar ridge and retromolar trigone cancers tend to invade bone early. Tumors of the inferior alveolar ridge may access the mandibular canal and the inferior alveolar nerve, whereas tumors of the superior alveolar ridge may pass into the maxillary antrum or floor of the nose.  Buccal mucosa cancer can invade the buccinator muscle, extend to the buccal fat pad, and invade the subcutaneous tissue. 38
  • 39. B. LYMPHATIC SPREAD-  The retro-styloid space is potentially at risk for involvement by metastatic disease when upper level II nodes are involved.  The principal lymphatic drainage of the upper lip is to preauricular, peri-parotid, submental, and submandibular lymph nodes.  The medial portion of the lower lip drains primarily to the submental lymph nodes, whereas the lateral portion drains to the submandibular triangle.  The anterior portion of the tongue drains to the submental nodes, and the lateral portion drains to the submandibular and deep jugular nodes. The posterior oral tongue drains into the upper jugulodigastric group of lymph nodes. 39
  • 40.  The lymphatics of the oral tongue have extensive communication across the midline, thus carcinomas of the oral tongue can metastasize bilaterally.  Some carcinomas of the lateral oral tongue may metastasize to level IV lymph nodes without involving levels I, II, or III. This implies that there may be separate lymphatic channels draining from the oral tongue directly to level IV nodes, allowing for apparent “skip metastases.”  The floor of the mouth has superficial and deep lymphatic drainage systems. The superficial system crosses randomly in the midline and drains into both the ipsilateral and contralateral submandibular lymph nodes. 40
  • 41. C. DISTANT METASTASIS-  The risk of distant metastases increases with the degree of lymph node involvement.  Patients with recurrent disease are also at higher risk for distant metastases.  In general terms, 66% of distant metastases are to the lungs, 22% to the bones, and 9.5% to the liver. 41
  • 43.  The predominant histopathologic type of cancer in the oral cavity is squamous cell carcinoma.  2 main variants of squamous cell carcinoma, including basaloid and verrucous carcinoma, and other variant being sarcomatoid carcinoma.  Basaloid squamous cell carcinoma has a worse prognosis due to higher incidence of advanced disease at presentation, distant metastases, and poorer overall survival rate.  Verrucous carcinoma is a less common variant of squamous cell carcinoma. It is generally considered a low-grade malignancy with low metastatic potential and good overall prognosis  Sarcomatoid carcinomas carry a poor prognosis, with a mean survival of approximately 2 years. 43
  • 44.  < 10% of neoplasms of the oral cavity have non-squamous histology.  Most of these are minor salivary gland tumors, which tend to arise in the hard palate.  Adenoid cystic carcinoma accounts for approximately 30% to 40% of minor salivary gland cancers of the oral cavity.  Other types includes adenocarcinomas, melanoma, ameloblastoma, lymphoma, and Kaposi sarcoma.  Most lymphomas in the head and neck arise in Waldeyer ring (tonsil, base of the tongue, and nasopharynx).  Melanomas are also present, with mucosal melanomas generally having a worse prognosis than cutaneous melanomas. 44
  • 46.  There are several pertinent changes from prior editions of the AJCC Staging Manual: (a) Clinical and pathologic depth of invasion are now used in indicating the T category. (b) Extrinsic tongue muscle involvement is no longer denoted as T4. (c) Separate N staging categories are now present for patients treated with and without neck dissection. (d) The presence of extra-nodal extension (ENE) is introduced as a descriptor of HPV negative squamous cell carcinoma. 46
  • 47. 47
  • 48. 48
  • 49. 49
  • 50. 50
  • 51. REFERENCES- 1. PEREZ & BRADY’S 2. DHINGRA’S ENT 3. ROBBINS PATHOLOGY 4. NCCN v.2018 5. GLOBOCAN 2022 6. AJCC 8TH Edition 51
  • 52. CA ORAL CAVITY PART 2 1. CLINICAL PRESENTATION 2. DIAGNOSTIC EVALUATION 3. MANAGEMENT- a) GENERAL OVERVIEW b) SURGERY c) RADIATION THERAPY d) CHEMOTHERAPY 52
  • 53. THANK YOU, AND HAVE A NICE DAY! 53